{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:51:06Z","timestamp":1793224266904,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jaci.2025.05.031","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:13:30Z","timestamp":1751422410000},"page":"911-922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7992","authenticated-orcid":false,"given":"P. Jane","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Azim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Diver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shrimanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koirobi","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.05.031_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGreggor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.05.031_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions and correlates among biologic-treated patients with severe asthma: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.05.031_bib6","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jaip.2023.05.047","article-title":"Response to biologics and clinical remission in the Adult German Asthma Net Severe Asthma Registry cohort","volume":"11","author":"Milger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.05.031_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/all.15867","article-title":"Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients","volume":"79","author":"Thomas","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.05.031_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1343362","article-title":"Features of severe asthma response to anti-IL5\/IL5r therapies: identikit of clinical remission","volume":"15","author":"Carpagnano","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.05.031_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1164\/rccm.202201-0129OC","article-title":"Exacerbation profile and risk factors in a type-2-low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes","volume":"206","author":"McDowell","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib10","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.jaip.2021.04.033","article-title":"Management strategies to reduce exacerbations in non-T2 asthma","volume":"9","author":"Murphy","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.05.031_bib11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202108-1943OC","article-title":"Endotyping chronic obstructive pulmonary disease, bronchiectasis and the \u201cchronic obstructive pulmonary disease-bronchiectasis association.\u201d","volume":"206","author":"Huang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib14","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1111\/all.15425","article-title":"Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation","volume":"77","author":"Diver","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.05.031_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2147\/COPD.S80091","article-title":"Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function","volume":"10","author":"Bafadhel","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jaci.2025.05.031_bib16","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.1203421","article-title":"Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration","volume":"191","author":"Al-Alwan","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.05.031_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","article-title":"Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"O\u2018Byrne","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1165\/rcmb.2020-0011OC","article-title":"Rhinovirus-induced CCL17 and CCL22 in asthma exacerbations and differential regulation by STAT6","volume":"64","author":"Williams","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.05.031_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.05.031_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11010-021-04315-x","article-title":"Inhibition of NETosis for treatment purposes: friend or foe?","volume":"477","author":"Chamardani","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jaci.2025.05.031_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02143-2021","article-title":"IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD","volume":"58","author":"Keir","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.05.031_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03312-2020","article-title":"Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD","volume":"58","author":"Winslow","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.05.031_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaci.2014.06.035","article-title":"Biological clustering supports both the \u201cDutch\u201d and \u201cBritish\u201d hypothesis of asthma and chronic obstructive pulmonary disease","volume":"135","author":"Ghebre","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.05.031_bib24","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biological clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/all.14058","article-title":"Sputum microbiomics clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup","volume":"75","author":"Diver","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.05.031_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/jcm6120112","article-title":"Airway mucous and asthma: the role of MUC5AC and MUC5B","volume":"6","author":"Bonser","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00079-5","article-title":"Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"9","author":"Radicioni","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0015-2023","article-title":"Basic, translational and clinical aspects of bronchiectasis in adults","volume":"32","author":"Chalmers","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2025.05.031_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2018.05.026","article-title":"Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation","volume":"143","author":"Jevnikar","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.05.031_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.05.031_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.chest.2024.02.048","article-title":"Effect of azithromycin on asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomized, double-anonymized, placebo-controlled trial","volume":"166","author":"Thomas","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.05.031_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thoraxjnl-2020-216331","article-title":"Add on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy","volume":"76","author":"Shukla","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.05.031_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides\u2014a systematic review of the underlying mechanisms","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.05.031_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1368-7646(98)80212-4","article-title":"Macrolide resistance","volume":"1","author":"Weisblum","year":"1998","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jaci.2025.05.031_bib36","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.05.031_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S2213-2600(22)00261-2","article-title":"Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"10","author":"Keir","year":"2022","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925006967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925006967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:57:18Z","timestamp":1778903838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925006967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0091674925006967"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.05.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}